Document Detail


Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
MedLine Citation:
PMID:  15503325     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To assess the diagnostic performance of three-dimensional dynamic liver imaging with sensitivity encoding (SENSE), including double arterial phase images and increased resolution, by comparing it to superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for the detection of hypervascular hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Twenty-seven consecutive patients with 50 HCCs underwent Gd-BOPTA-enhanced dynamic imaging using SENSE and SPIO-enhanced MR imaging with at least a 24-hour interval between examinations. Using a three-dimensional gradient-echo technique applying SENSE, dynamic imaging consisting of double arterial phase-, portal phase- and delayed phase-images, was obtained. Using T2-weighted turbo spin-echo and T2*-weighted fast imaging with steady-state precession sequence, SPIO-enhanced MR imaging was obtained. For qualitative analysis, the diagnostic accuracy of both MR examinations for detecting the 50 HCCs was evaluated using the alternative free-response receiver operating characteristic method. Sensitivity and positive predictive value were also evaluated. RESULTS: The mean sensitivity and positive predictive value of three-dimensional dynamic imaging with SENSE were 91.3% and 89.2%, respectively, and those of SPIO-enhanced imaging were 77.3% and 92.6 %, respectively. There was a significant difference in sensitivity between the two images (P <0.05). The mean Az value of three-dimensional dynamic imaging with SENSE (0.97 +/- 0.01) was significantly higher than that of SPIO-enhanced imaging (0.90 +/- 0.02) (P=0.00). CONCLUSION: Three-dimensional dynamic liver MR imaging using SENSE for acquiring double arterial phase images is more efficient than SPIO-enhanced MR imaging for detecting HCCs.
Authors:
Young Kon Kim; Chong Soo Kim; Hyo Sung Kwak; Jeong Min Lee
Related Documents :
7484575 - Mr diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relat...
8656985 - A simple mr-compatible infusion pump.
8134585 - Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment with dynamic con...
8387805 - Dynamic mr imaging of hepatoma treated by transcatheter arterial embolization therapy. ...
7992745 - Vascular contact with the fifth cranial nerve at the pons in patients with trigeminal n...
8358955 - Nuclear magnetic resonance imaging and spectroscopy following asphyxia.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of magnetic resonance imaging : JMRI     Volume:  20     ISSN:  1053-1807     ISO Abbreviation:  J Magn Reson Imaging     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-10-29     Completed Date:  2005-03-03     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9105850     Medline TA:  J Magn Reson Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  826-37     Citation Subset:  IM    
Affiliation:
Department of Diagnostic Radiology, Chonbuk National University Medical School and Hospital, Chonju, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Hepatocellular / diagnosis*
Contrast Media / administration & dosage
Female
Ferrosoferric Oxide
Humans
Image Enhancement / methods*
Imaging, Three-Dimensional / methods*
Iron / diagnostic use*
Liver / pathology*
Liver Neoplasms / diagnosis*
Magnetic Resonance Imaging / methods*
Male
Meglumine / analogs & derivatives*,  diagnostic use
Middle Aged
Observer Variation
Organometallic Compounds / diagnostic use
Oxides / diagnostic use*
Predictive Value of Tests
ROC Curve
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Organometallic Compounds; 0/Oxides; 113662-23-0/gadobenic acid; 119683-68-0/ferumoxides; 1317-61-9/Ferrosoferric Oxide; 6284-40-8/Meglumine; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, ...
Next Document:  Glomerular filtration rate: assessment with dynamic contrast-enhanced MRI and a cortical-compartment...